-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905. Outcomes Research—Malignant Conditions (Lymphoid Disease): Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, AML, Biological, Coronaviruses, Follicular Lymphoma, Leukemia, multiple myeloma, SARS-CoV-2/COVID-19, Diseases, Lymphoma (any), Non-Biological, CAR-Ts, Combinations, Elderly, Hodgkin Lymphoma, Therapies, Adverse Events, chemotherapy, Non-Hodgkin Lymphoma, Pediatric, B-Cell Lymphoma, DLBCL, immunodeficiency, Immune Disorders, T-Cell Lymphoma, Young Adult, immunotherapy, Plasma Cell Disorders, Lymphoid Malignancies, Study Population, Clinically relevant, Myeloid Malignancies, Quality Improvement , transplantation, TKI, stem cells
Monday, December 7, 2020: 7:00 AM-3:30 PM

Michel Delforge, MD PhD1, Nina Shah, MD2, Paula Rodriguez-Otero3*, Parameswaran Hari, MBBS, MD4, Julia Braverman, PhD5*, Andrew Trigg6*, Payal Patel5*, Liping Huang, PhD5*, Kristen Hege5 and Sujith Dhanasiri7*

1Department of Hematology, University Hospital Leuven, Leuven, Belgium
2Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
3Clínica Universidad de Navarra, Pamplona, Spain
4Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Brookfield, WI
5Bristol Myers Squibb, Princeton, NJ
6Adelphi Values, Bollington, United Kingdom
7Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland

Renata Abrahao, MD, PhD, MSc1,2, Ann M Brunson, MS3*, Justine M. Kahn, MD, MSc4,5, Qian Li, MS6*, Aaron S Rosenberg, MD7, Ted Wun, MD6 and Theresa Keegan, PhD, MS6,8

1Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology, University of California Davis Medical Center, Berkeley, CA
2Center for Healthcare Policy & Research, University of California Davis Medical Center, Sacramento, CA
3Center for Oncology Hematology Outcomes Research and Training (COHORT) and Division of Hematology and Oncology, University of California Davis School of Medicine, University of California, Davis School of Medicine, Sacramento, CA
4Pediatric Hematoloy/Oncology, Columbia University Irving Medical Center, Brooklyn, NY
5Division of Pediatric Hematology/Oncology, Columbia University Irving Medical Center, New York, NY
6Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA
7Department of Internal Medicine, Division of Hematology and Oncology, University of California, Davis, Sacramento, CA
8University of California, Davis, Sacramento, CA

Kartik Anand1*, Sai Ravi Kiran Pingali, MD2 and Joe Ensor, PhD2*

1Callahan Cancer Center, Great Plains Health, North Platte, NE
2Houston Methodist Cancer Center, HOUSTON, TX

Gerardo Manuel Rosas, MD1*, Sushanth Kakarla, MBBS2, Brian Warnecke, DO1*, Sarah Allison Smith, MD3*, Joel E Michalek, PhD4*, Qianqian Liu, PhD5* and Adolfo Enrique Diaz Duque, MD, MSc6

1University of Texas Health Science Center San Antonio, San Antonio, TX
2Hematology, Mays Cancer Center UT Health San Antonio MD Anderson, San Antonio, TX
3Internal Medicine, University of Texas Health Sciences Center San Antonio, San Antonio, TX
4The University of Texas Health Science Center At San Antonio, San Antonio, TX
5Department of Epidemiology and Biostatistics, University of Texas Health at San Antonio, San Antonio, TX
6Hematology-Oncology Division, Mays Cancer Center UT Health San Antonio MD Anderson, San Antonio, TX

Wei-Ying Jen, BM BCh, FRCPath1, Zhi Yao Chan, MSc (Clin Pharm)2*, Mary Chong, BN3*, Mariana Ibrahim, BSN3*, Melinda Khoo, BSc (Hons)4*, Judith Lee, BN, MSOL3*, Meng Tuck Lee, Dipl.-Ing. Univ.4*, Yee Mei Lee, BSN, MN, PhD3*, Siew Woon Lim, MSc (Clin Pharm)2*, Noel Ng, BBus(Mgt)4*, Ednajoy Ngo, BHSN, MN3*, Belinda Tan, BHSN, GradDipNsg(Onc)3*, Rui Xian Tay, MBA4*, Constance Teo, MSc (Clin Pharm)2*, Yuet Peng Wong, MSc (Clin Pharm)2*, Cheng Ean Chee, MBBS, ABIM (Med Onc), ABIM (Heme), FCAP1* and Yen-Lin Chee, MB ChB, FRCPath, PhD1*

1Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore, Singapore
2Department of Pharmacy, National University Hospital, Singapore, Singapore
3Division of Oncology Nursing, National University Cancer Institute, Singapore, Singapore, Singapore
4Operations and Administration, National University Cancer Institute, Singapore, Singapore, Singapore

Sharon M. Castellino, MD, MSc1,2,3, Angela Punnett, MD4*, Susan K Parsons, MD, MRP5, Nicholas P. DeGroote, MPH2*, Sally Muehle6*, Hongli Li, MS7*, Michael E. Roth, MD8*, Alex F. Herrera, MD9, Jonathan W. Friedberg, MD, MSSc10, Nita L. Seibel, MD11 and Kara M. Kelly, MD12

1Aflac Cancer and Blood Disorders Center, Emory University School of Medicine / Children's Healthcare of Atlanta, Atlanta, GA
2Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
3Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
4Hospital for Sick Children, Toronto, ON, Canada
5Tufts Medical Center, Tufts University School of Medicine, Boston, MA
6University Hospital- Rainbow Babies and Children's, Cleveland, OH
7SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, WA
8MD Anderson Cancer Center, Houston, TX
9City of Hope, Duarte, CA
10Division of Hematology/Oncology, University of Rochester, Rochester, NY
11Cancer Therapy Evaluation Prgm., NCI, Bethesda, MD
12Department of Pediatric Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Ajibade O Ashaye, MD, MBA, MPH, MSc.1*, Caitlin Thomas, MSc2*, Mehul Dalal, PhD1*, Vamsi Kota, MD3, Nicolas Krucien, PhD2*, Maria Sae-Hau, PhD4*, Meredith Barnhart, PhD, LCSW-R, OSW-C4*, Elisa S. Weiss, PhD4*, Scott Campbell, BSc1* and Kevin Marsh, PhD2*

1Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd., Cambridge, MA
2Evidera, London, United Kingdom
3Georgia Cancer Center Augusta University, Augusta, GA
4The Leukemia & Lymphoma Society, Rye Brook, NY

Smith Giri, MD1, Susan Bal, MD, MBBS2, Kelly N. Godby, MD1*, Grant R Williams3*, Luciano J. Costa, MD, PhD4 and Smita Bhatia, MD, MPH3

1University of Alabama at Birmingham, Birmingham, AL
2O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
3Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
4O’ Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Vestavia, AL

Jason N Barreto, PharmD1, Corina J Doleski, PharmD1*, Justin R Hayne, PA-C2*, Matthew A Hathcock2*, Tuan A Truong2*, Stephen M. Ansell, MD, PhD3, Nabila Nora Bennani, MD2, Jonas Paludo, MD4, Jose C Villasboas, MD2, Yi Lin, MD, PhD4 and Patrick B. Johnston, MD/ PhD2

1Department of Pharmacy, Mayo Clinic, Rochester, MN
2Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
3Mayo Clinic, Rochester, MN
4Division of Hematology, Mayo Clinic, Rochester, MN

Emily J. Labudde1*, Nicholas P. DeGroote, MPH2*, Susie Smith, RN3*, Jonathan Ebelhar, MD3,4*, Sharon M. Castellino, MD, MSc1,2, Karen Wasilewski-Masker, MD, MSc3,4* and Katharine E. Brock, MD3,5,6*

1Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
2Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
3Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta
4Department of Pediatrics, Division of Hematology/Oncology, Emory University School of Medicine, Atlanta
5Department of Pediatrics, Division of Pediatric Hematology/Oncology, Emory University School of Medicine, Atlanta
6Department of Pediatrics, Division of Pediatric Palliative Care, Emory University School of Medicine, Atlanta

Eric M. Ammann, PhD1*, Annette Lam, MSc2*, Wenze Tang, MPH1,3*, Tobias Kampfenkel, MD4, Mohit Sharma5*, Charlene Lee, MSc2*, Shuchita Kaila, PhD1*, Alex Z. Fu, PhD1*, Kathleen Gray, PhD1* and Jianming He, PhD2*

1Janssen Scientific Affairs, Horsham, PA
2Janssen Global Services, Raritan, NJ
3Harvard TH Chan School of Public Health, Cambridge, MA
4Janssen Research & Development, LLC, Leiden, Netherlands
5Mu Sigma, Bangalore, India

Laura Tapley, M.D.1, Pamela Skrabek, M.D.1, Pascal Lambert, M.Sc.2*, Jenniebie Bravo, M.Sc.2*, Kathleen Decker, PhD2*, Piotr Czaykowski, M.D.1*, Donna Turner, M.D.2*, Phil St. John, M.D.3* and David Dawe, M.D.4*

1Section of Hematology and Medical Oncology, Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
2Epidemiology and Cancer Registry, Research Institute in Oncology and Hematology CancerCare Manitoba, Winnipeg, MB, Canada
3Section of Geriatrics, Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
4Research Institute in Oncology and Hematology, CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada

Albert Oriol1*, Paul G. Richardson, MD2, María-Victoria Mateos, MD, PhD3, Alessandra Larocca4, Joan Blade Creixenti5, Michele Cavo6*, Paula Rodríguez-Otero, MD7*, Maxim Norkin, MD, PhD8*, Omar Nadeem, MD2*, John W. Hiemenz, MD9*, Hani Hassoun, MD10, Cyrille Touzeau11,12,13*, Adrián Alegre Amor, MD, PhD14*, Agne Paner, MD15, Christopher Maisel, MD16, Amitabha Mazumder, MD17*, Anastasios Raptis, MD18, Noemí Puig, MD, PhD3*, Peter Strang, MD19*, Anna Sandberg, MmSc20*, Christian Jaques, MD20*, Marcus Thuresson, PhD21*, Marie Orre, PhD20* and Xavier Leleu, MD22

1Institut Català d’Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
2Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
3Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain
4Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy
5Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain
6Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
7Clínica Universidad de Navarra, Pamplona, Spain
8Baptist MD Anderson Cancer Center, Jacksonville, FL
9Division of Hematology-Oncology, Department of Medicine, University of Florida, Gainesville, FL
10Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
11Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université d'Angers, Université de Nantes, Nantes, France
12Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France
13Service d'hématologie Clinique, Centre Hospitalier Universitaire, Place Alexis Ricordeau, Nantes, France
14Hospital Universitario La Princesa and Hospital Universitario Quironsalud, Madrid, Spain
15Rush University Medical Center, Chicago, IL
16Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, TX
17The Oncology Institute of Hope and Innovation, Glendale, CA
18Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
19Karolinska Institutet, Stockholm, Sweden
20Oncopeptides AB, Stockholm, Sweden
21Statisticon AB, Stockholm, Sweden
22CHU de Poitiers, Poitiers, France

Ahmed Sawas, MD1, Constance Lau, MPH1*, Michael Thomson, MS1* and Kathleen Maignan, NP, MSN2*

1Flatiron Health, Inc., New York, NY
2Flatiron Health Inc, New York, NY

Chieh-Lin Jerry Teng1*, Tran-Der Tan, MD 2, Yu-Wen Lin3*, Pei-Wen Lien4*, Hsin-Chun Chou4* and Fang-Ju Lin3*

1Division of Hematology/Medical Oncology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan
2Department of Hematology and Medical Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan
3Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan
4Takeda Pharmaceuticals Taiwan, Taipei, Taiwan

Jessica Marini, PharmD1*, Andy Maldonado, PharmD, BCOP1*, Erin R Weeda, PharmD, BCPS1*, Hamza Hashmi, MD2, Amarendra K. Neppalli, MD3 and Kathy Edwards, PharmD, BCPS, BCOP, HRM1*

1Medical University of South Carolina, Charleston, SC
2Department of Hematology/Medical Oncology, Medical University of South Carolina, Charleston, SC
3Hollings Cancer Center, Medical University of South Carolina, Charleston, SC

Jun Yang Jiang1* and Erin Reid, MD, MS2

1Department of Internal Medicine, University of California San Diego Health, San Diego, CA
2Moores Cancer Center, University of California San Diego Health, San Diego, CA

A Hart1*, Y S Ahn2*, C Watson, MS3*, M Skeans2*, A Barlev3*, B Thompson2* and VR Dharnidharka4*

1Hennepin County Medical Center, University of Minnesota, Minneapolis, MN
2Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, MN
3Atara Biotherapeutics, South San Francisco, CA
4Washington University School of Medicine & St. Louis Children’s Hospital, St Louis, MO

Lauren Willis, PharmD, BCOP1, Donna Topping, PharmD, BCOP2*, Sarah Atwood, MPH2* and Jonathon B. Cohen, MD, MS3

1Medscape Education, LLC, Lexington, KY
2Medscape Education, LLC, New York, NY
3Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA

Angelica D'Aiello, MD1*, Sumaira Zareef, MD2*, Kith Pradhan, PhD2*, Amanda Lombardo, PA-C, BS, MS2*, Fariha Khatun, PA-C2*, Jennat Mustafa, PA-C2*, Alyssa De Castro, PharmD2*, Felisha Joseph, PA-C2*, Kailyn Gillick, PA-C2*, Anjali Naik, PA-C2*, Astha Thakkar, MBBS3, Lauren C Shapiro, MD4*, Shafia Rahman, MD4, Zhu Cui, MD2*, Jesus D Gonzalez Lugo, MD4*, Fiona Mienko, MBBS4, Numa Tarnima Rahman, MD4, Robert Lopez, MD4, Heidi Chwan Ko, DO4, Amanda Podolski, MD4, Vikas Mehta, MD5*, Sanjay Goel, MD4*, Rafi Kabarriti, MD6*, Joseph Sparano, MD4*, Stuart Packer, MD4*, David Lawrence Fernandes, MD4*, Enrico Castelucci, MD4*, Margarita Kushnir, MD4, Mark Chaitowitz, MD3, Luca Paoluzzi, MD4*, Ulrich G. Steidl, MD/PhD7, Phaedon Zavras, MD2*, Ioannis Mantzaris, MD, MS4, Noah Kornblum, MD4*, Aditi Shastri, MD4, Lizamarie Bachier-Rodriguez, MD2*, Kira Gritsman, MD, PhD8, Henny H. Billett, MD, MSc4, Rachel Bartash, MD9*, Yoram Puius, MD, PhD9*, Margaret Mccort, MD9*, Ira Braunschweig, MD4*, Mendel Goldfinger, MD4*, Amit Verma, MBBS4 and R. Alejandro Sica, MD3

1Montefiore Medical Center/Albert Einstein College of Medicine, NY, NY
2Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
3Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, New York, NY
4Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
5Otolaryngology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
6Radiation Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
7Hematology/Oncology, Albert Einstein College of Medicine, Bronx, NY
8Albert Einstein College of Medicine, Bronx, NY
9Infectious Disease, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

Erin Mullane1*, Taylor Jones1*, Jenna Voutsinas, MPH1*, Qian Vicky Wu, PhD1*, Elizabeth Loggers, MD, PhD2*, Jesse Fann3*, David G. Maloney, MD, PhD4 and Merav Bar4

1Fred Hutchinson Cancer Research Center, Seattle
2Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
3University of Washington, Seattle, WA
4Fred Hutchinson Cancer Research Center, Seattle, WA

*signifies non-member of ASH